Almujtama Alraida Medical Co.
Almujtama Alraida Medical Co. (9592.SR) Revenue
Annual & quarterly revenue history · segment & region breakdown
9592.SR · revenue · updated Jun 15, 2026
Core revenue metrics
Trailing 12 monthsAlmujtama Alraida Medical Co. trailing twelve-month (TTM) revenue is $0.89B, an increase of 5.57% year-over-year from $0.45B in FY2025.
Revenue trend
2025 – 2021 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.45B | +$0.02B | +5.57% |
| 2024-12-31 | $0.43B | +$0.02B | +5.64% |
| 2023-12-31 | $0.41B | +$0.04B | +11.08% |
| 2022-12-31 | $0.37B | +$0.06B | +20.55% |
| 2021-12-31 | $0.30B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Almujtama Alraida Medical Co. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Almujtama Alraida Medical Co. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in SAR.
Data sourced from Almujtama Alraida Medical Co.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
9592.SR revenue · 4 questions9592.SR's trailing twelve-month (TTM) revenue is $0.89B. That is an increase of 5.57% year-over-year from $0.45B in FY2025.
▸ Source: FMP · Almujtama Alraida Medical Co. SEC filings · GAAP · Almujtama Alraida Medical Co. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 15, 2026